KENNETH I MOCH Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KENNETH I MOCH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH I MOCH. KENNETH I MOCH is CEO, President & Chairman in Synvista Therapeutics, Inc. ($ALT) and Director in Zynerba Pharmaceuticals, Inc. ($ZYNE).
Latest Insider Trading Transactions of KENNETH I MOCH
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2020 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 5.21 | 15,000 | 78,150 | 15,000 | |
Jul 03 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 14.11 | 666 | 9,397 | 666 | |
Jun 13 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
Apr 03 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 5.40 | 1,728 | 9,331 | 1,728 | |
Jan 04 2019 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 3.72 | 2,450 | 9,114 | 2,450 | |
Oct 02 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.86 | 1,152 | 9,055 | 1,152 | |
Jul 03 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 9.70 | 952 | 9,234 | 952 | |
Jun 07 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 11.30 | 15,000 | 169,500 | 15,000 | |
Apr 03 2018 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.98 | 1,161 | 9,265 | 1,161 | |
Oct 03 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 8.69 | 971 | 8,438 | 971 | |
Jul 06 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 16.90 | 500 | 8,450 | 500 | |
Jun 09 2017 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 18.77 | 15,000 | 281,550 | 15,000 | |
Jul 20 2016 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 7.90 | 15,000 | 118,500 | 15,000 | |
Aug 06 2015 | ZYNE | Zynerba Pharmaceut ... | MOCH KENNETH I | Director | Option Exercise | A | 14.00 | 35,000 | 490,000 | 35,000 | |
Jul 21 2006 | ALT | Synvista Therapeut ... | MOCH KENNETH I | CEO, President & Ch ... | Option Exercise | A | 0.15 | 70,000 | 10,500 | 3,032,000 | |
Jul 21 2006 | ALT | Synvista Therapeut ... | MOCH KENNETH I | CEO, President & Ch ... | Grant | A | 0.00 | 160,000 | 0 | 2,962,000 | 2.8 M to 3 M (+5.71 %) |
Mar 02 2005 | ALT | Synvista Therapeut ... | MOCH KENNETH I | CEO, President & Ch ... | Option Exercise | A | 0.75 | 150,000 | 112,500 | 150,000 | |
Dec 09 2004 | ALT | Synvista Therapeut ... | MOCH KENNETH I | CEO, President & Ch ... | Option Exercise | A | 1.03 | 500,000 | 515,000 | 500,000 | |
Dec 09 2004 | ALT | Synvista Therapeut ... | MOCH KENNETH I | CEO, President & Ch ... | Option Exercise | A | 1.03 | 100,000 | 103,000 | 100,000 |
Page: 1